Du Yifei, Zuber Philipp Konrad, Xiao Huajuan, Li Xueyan, Gordiyenko Yuliya, Ramakrishnan V
MRC Laboratory of Molecular Biology, Cambridge, UK.
Independent researcher, Cambridge, UK.
Nat Biomed Eng. 2024 Dec 13. doi: 10.1038/s41551-024-01306-3.
Circular RNA (circRNA) is a candidate for next-generation messenger RNA therapeutics owing to its remarkable stability. Here we describe trans-splicing-based methods for the synthesis of circRNAs over 8,000 nucleotides. The methods are independent of bacterial sequences, outperform the permuted intron-exon method and allow for the incorporation of RNA modifications. The resulting unmodified circRNAs, which incorporate sequences from human 28S ribosomal RNA, display low immunogenicity and are translated more efficiently than permuted intron-exon-derived circRNAs. Additionally, by using viral internal ribosomal entry sites for rolling circle translation, we show that ribosomes can efficiently read through highly structured internal ribosomal entry sites, enhancing the efficiency of rolling circle translation by over 7,000-fold with respect to previous constructs. The efficient and reliable production of circRNA may facilitate its therapeutic use.
环状RNA(circRNA)因其卓越的稳定性而成为下一代信使RNA疗法的候选分子。在此,我们描述了基于反式剪接的方法来合成超过8000个核苷酸的circRNA。这些方法不依赖于细菌序列,优于置换内含子-外显子方法,并允许引入RNA修饰。所得的未修饰circRNA包含来自人类28S核糖体RNA的序列,显示出低免疫原性,并且比置换内含子-外显子衍生的circRNA翻译效率更高。此外,通过使用病毒内部核糖体进入位点进行滚环翻译,我们表明核糖体能够有效地通读高度结构化的内部核糖体进入位点,相对于先前的构建体,滚环翻译效率提高了7000倍以上。circRNA的高效可靠生产可能会促进其在治疗中的应用。